# FDA Inspection 846717 - Carter BloodCare - August 29, 2013

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/558f2fb7-eba6-45cb-8fa7-f4035e545e53
Source feed: FDA_Inspections

> FDA Inspection 846717 for Carter BloodCare on August 29, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 846717
- Company Name: Carter BloodCare
- Inspection Date: 2013-08-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1217918 - 2023-08-22](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/baa85066-ef5a-4c5b-953b-c2214b105f6c)
- [FDA Inspection 1093449 - 2019-04-12](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/22de263a-cd6d-4365-a18d-7cf6afa730aa)
- [FDA Inspection 1033975 - 2017-12-06](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/5b928782-bdfe-46a1-84fb-78e39dcb3cf5)
- [FDA Inspection 736481 - 2011-07-27](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/496721d8-2462-46d6-8502-3ae33bf60da4)
- [FDA Inspection 604811 - 2009-08-17](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/5bfe2dad-2ae1-4e91-b3d9-adabef54a91f)

Company: https://www.keypedia.com/companies/carter-bloodcare/1110476b-aead-4d21-99d5-13411d4ba96f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d